3-[1-(4-Butoxybenzoyl)piperidin-4-yl]-4-[(4-methylphenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one CAS 1775410-20-2
Purity 97%+In StockPharmaceutical Standards
| CAS No. | 1775410-20-2 |
| Molecular Formula | C26H32N4O3 |
| Molecular Weight | 448.56 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
3-[1-(4-Butoxybenzoyl)piperidin-4-yl]-4-[(4-methylphenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one (CAS 1775410-20-2) reference standard, produced by CATO (ISO 17034 / CNAS / ANAB accredited). Molecular formula: C26H32N4O3. Molecular weight: 448.56 g/mol. Trusted by 10,000+ laboratories worldwide for pharmaceutical analysis and QC.
Physical & Chemical Properties
| Molecular Formula | C26H32N4O3 |
| Molecular Weight | 448.56 g/mol |
| Appearance | Pale yellow to yellow crystalline powder |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 13.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1994 |
| Nitrogen Atoms | 4 |
Related Butoxybenzoyl Standards
- 1-(4-Butoxybenzoyl)-4-{[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine (CAS 1775482-34-2)
- 1-(4-Butoxybenzoyl)-4-{[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine (CAS 1775302-57-2)
- 4-(4-Butoxybenzoyl)-3-hydroxy-1-(5-methyl-1,3,4-thiadiazol-2-yl)-5-(p-tolyl)-1H-pyrrol-2(5H)-one (CAS 609795-42-8)
- 4-(4-Butoxybenzoyl)-5-(2-fluorophenyl)-3-hydroxy-1-(5-methyl-1,3,4-thiadiazol-2-yl)-1H-pyrrol-2(5H)-one (CAS 609795-73-5)
- 4-(4-Butoxybenzoyl)-5-(4-fluorophenyl)-3-hydroxy-1-(5-methyl-1,3,4-thiadiazol-2-yl)-1H-pyrrol-2(5H)-one (CAS 617695-21-3)
- 5-[1-(4-Butoxybenzoyl)pyrrolidin-2-yl]-3-(4-methoxyphenyl)-1,2,4-oxadiazole (CAS 1046006-43-2)
- 4-(4-Butoxybenzoyl)-5-(4-ethylphenyl)-3-hydroxy-1-(5-methyl-1,3,4-thiadiazol-2-yl)-1H-pyrrol-2(5H)-one (CAS 609796-74-9)
- 1-(4-Butoxybenzoyl)-4-[(3-phenyl-1,2,4-oxadiazol-5-yl)methyl]piperidine (CAS 1775468-02-4)
Recommended Standards
- 3-[1-(4-tert-Butylbenzoyl)piperidin-4-yl]-4-[(4-methoxyphenyl)methyl]-4,5-dihydro-1H-1,2,4-triazol-5-one (CAS 1775380-27-2)
- (1S)-[2,2'-Bis(4,4-dimethyl-4,5-dihydrooxazol-2-yl)-1,1'-binaphthalene (CAS 93531-05-6)
- 5-Ethyl-3-[4-(4-methoxyphenyl)piperazine-1-carbonyl]-5H,5aH,6H,7H,8H,9H,11H-pyrido[2,1-b]quinazolin-11-one (CAS 1574585-28-6)
- Humanlenirine (CAS 82375-30-2)
- (2-(Isopentyloxy)phenyl)methanol (CAS 500547-94-4)
- 4-Amino-3-chloropyridazine (CAS 55928-83-1)
- 2-Bromo-1-(bromomethyl)-3-chlorobenzene (CAS 220453-60-1)
- 3-(1h-1,3-Benzodiazol-2-yl)cyclohexan-1-amine (CAS 933759-56-9)
- 5-Isopropyl-2-oxo-1,3-oxazolidine-4-carboxylic acid (CAS 1468529-36-3)
- D-Ser12-Semaglutide (CAS CATO-C4X-2226240)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 13829788188 / jacky.chen@cato-chem.com